<i>Tisochrysis lutea</i> F&M-M36 Mitigates Risk Factors of Metabolic Syndrome and Promotes Visceral Fat Browning through β3-Adrenergic Receptor/UCP1 Signaling
Pre-metabolic syndrome (pre-MetS) may represent the best transition phase to start treatments aimed at reducing cardiometabolic risk factors of MetS. In this study, we investigated the effects of the marine microalga <i>Tisochrysis lutea</i> F&M-M36 (<i>T. lutea</i>) on cardiometabolic components of...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI AG
2023-05-01
|
| Серии: | Marine Drugs |
| Предметы: | |
| Online-ссылка: | https://www.mdpi.com/1660-3397/21/5/303 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
